Perspective Therapeutics, Inc.CATXNYSE
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q4 2025 | -13.97% |
| Q3 2025 | -13.28% |
| Q2 2025 | -4.43% |
| Q1 2025 | -4.41% |
| Q4 2024 | -11.51% |
| Q3 2024 | -9.10% |
| Q2 2024 | 10.19% |
| Q1 2024 | 239.12% |
| Q4 2023 | -23.88% |
| Q3 2023 | -9.10% |
| Q2 2023 | -7.94% |
| Q1 2023 | 114.57% |
| Q4 2022 | -4.67% |
| Q3 2022 | -5.83% |
| Q2 2022 | -3.04% |
| Q1 2022 | -1.85% |
| Q4 2021 | -2.08% |
| Q3 2021 | -2.44% |
| Q2 2021 | -1.02% |
| Q1 2021 | 706.40% |
| Q4 2020 | 107.98% |
| Q3 2020 | -12.04% |
| Q2 2020 | -2.38% |
| Q1 2020 | -5.50% |
| Q4 2019 | -11.70% |
| Q3 2019 | -9.48% |
| Q2 2019 | -10.84% |
| Q1 2019 | -10.91% |
| Q4 2018 | -14.53% |
| Q3 2018 | 85.18% |
| Q2 2018 | -24.47% |
| Q1 2018 | -16.01% |
| Q4 2017 | -14.00% |
| Q3 2017 | -13.73% |
| Q2 2017 | -13.43% |
| Q1 2017 | -9.73% |
| Q4 2016 | -9.40% |
| Q3 2016 | -8.70% |
| Q2 2016 | -6.40% |
| Q1 2016 | -5.55% |